Drug shortages homepage
Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.
Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.
The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.
Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.
If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.
Below are the newest shortage and discontinuation reports and updates to existing ones.
LEGEND
!!T3 denotes an actual Tier 3 shortage/discontinuation
!T3 denotes an anticipated Tier 3 shortage/discontinuation
Shortage Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| TRAZODONE | SANIS HEALTH INC | Resolved | 50MG | Updated Report | 2025-11-08 | 265016 |
| STROMECTOL | MERCK CANADA INC | Actual shortage | 3MG | Updated Report | 2025-11-08 | 271325 |
| OLOPATADINE 0.2% | SANIS HEALTH INC | Resolved | 0.2% | Updated Report | 2025-11-08 | 268678 |
| PREGABALIN | SANIS HEALTH INC | Resolved | 50MG | Updated Report | 2025-11-08 | 268681 |
| DANTRIUM INTRAVENOUS | ENDO OPERATIONS LTD. | Resolved | 20MG | Updated Report | 2025-11-08 | 269411 |
| METHOTREXATE SUBCUTANEOUS | ACCORD HEALTHCARE INC | Actual shortage | 20MG | Updated Report | 2025-11-08 | 271316 |
| CEPHALEXIN | SANIS HEALTH INC | Actual shortage | 500MG | Updated Report | 2025-11-08 | 268696 |
| MAGNESIUM SULFATE INJECTION, USP | FRESENIUS KABI CANADA LTD | Anticipated shortage | 500MG | Updated Report | 2025-11-07 | 271349 |
| COLY-MYCIN M | SEARCHLIGHT PHARMA INC | Anticipated shortage | 150MG | Updated Report | 2025-11-07 | 252101 |
| APO-RIZATRIPTAN | APOTEX INC | Resolved | 10MG | Updated Report | 2025-11-07 | 269335 |
| APO-LEVOTHYROXINE | APOTEX INC | Resolved | 112MCG | Updated Report | 2025-11-07 | 260693 |
| APO-LEVOTHYROXINE | APOTEX INC | Resolved | 50MCG | Updated Report | 2025-11-07 | 265284 |
| APO-ACYCLOVIR OINTMENT | APOTEX INC | Actual shortage | 5% | Updated Report | 2025-11-07 | 269754 |
| APO-ACETAMINOPHEN | APOTEX INC | Resolved | 325MG | Updated Report | 2025-11-07 | 262446 |
| ACETAMINOPHEN CAPLETS 500 MG | APOTEX INC | Resolved | 500MG | Updated Report | 2025-11-07 | 266069 |
| MYA | APOTEX INC | Resolved | 0.02MG 3.00MG | Updated Report | 2025-11-07 | 270735 |
| APO-DASATINIB | APOTEX INC | Actual shortage | 20MG | Updated Report | 2025-11-07 | 265269 |
| !!T3 FLUDARABINE PHOSPHATE INJECTION, USP | ACCORD HEALTHCARE INC | Actual shortage | 25MG | Updated Report | 2025-11-07 | 247144 |
| ACH-METHOTREXATE | ACCORD HEALTHCARE INC | Actual shortage | 2.5MG | Updated Report | 2025-11-07 | 254876 |
| ACH-ROSUVASTATIN | ACCORD HEALTHCARE INC | Actual shortage | 20MG | New Report | 2025-11-07 | 271313 |
| CLINDOXYL GEL | GLAXOSMITHKLINE INC | Actual shortage | 5% 1% | Updated Report | 2025-11-07 | 261877 |
| SINEQUAN | AA PHARMA INC | Actual shortage | 75MG | New Report | 2025-11-07 | 271306 |
| DESMOPRESSIN SPRAY | AA PHARMA INC | Actual shortage | 10MCG | New Report | 2025-11-07 | 271301 |
| PHENYTOIN SODIUM | AA PHARMA INC | Actual shortage | 100MG | New Report | 2025-11-07 | 271294 |
| KETOROLAC | AA PHARMA INC | Actual shortage | 0.5% | Updated Report | 2025-11-07 | 269004 |
| OLOPATADINE 0.2% | SANIS HEALTH INC | Actual shortage | 0.2% | Updated Report | 2025-11-07 | 266471 |
| LITHMAX | AA PHARMA INC | Actual shortage | 300MG | Updated Report | 2025-11-07 | 261865 |
| DEXTROAMPHETAMINE | AA PHARMA INC | Actual shortage | 5MG | Updated Report | 2025-11-07 | 268263 |
| PROCHLORAZINE | AA PHARMA INC | Resolved | 10MG | Updated Report | 2025-11-07 | 268269 |
| BRIMONIDINE P | AA PHARMA INC | Resolved | 0.15% | Updated Report | 2025-11-07 | 266906 |
| OLMESARTAN | SANIS HEALTH INC | Actual shortage | 40MG | Updated Report | 2025-11-07 | 266468 |
| FLUOXETINE | SANIS HEALTH INC | Actual shortage | 20MG | Updated Report | 2025-11-07 | 266459 |
| ESCITALOPRAM | SANIS HEALTH INC | Actual shortage | 20MG | Updated Report | 2025-11-07 | 266487 |
| MYLAN-TADALAFIL | MYLAN PHARMACEUTICALS ULC | Actual shortage | 10MG | Updated Report | 2025-11-07 | 269965 |
| QUILLIVANT ER CHEWABLE TABLETS | KYE PHARMACEUTICALS INC. | Actual shortage | 20MG | Updated Report | 2025-11-07 | 271115 |
| APO-LANSOPRAZOLE | APOTEX INC | Resolved | 15MG | Updated Report | 2025-11-07 | 265826 |
| HALOETTE | SEARCHLIGHT PHARMA INC | Anticipated shortage | 11.7MG 2.7MG | Updated Report | 2025-11-06 | 266226 |
| VANCOCIN | SEARCHLIGHT PHARMA INC | Resolved | 125MG | Updated Report | 2025-11-06 | 263233 |
| VANCOCIN | SEARCHLIGHT PHARMA INC | Resolved | 250MG | Updated Report | 2025-11-06 | 263238 |
| APO-ESOMEPRAZOLE | APOTEX INC | Actual shortage | 20MG | Updated Report | 2025-11-06 | 271260 |
| APO-SITAGLIPTIN MALATE | APOTEX INC | Actual shortage | 50MG | Updated Report | 2025-11-06 | 271257 |
| APO-TOPIRAMATE | APOTEX INC | Actual shortage | 100MG | New Report | 2025-11-06 | 271254 |
| APO-DULOXETINE | APOTEX INC | Actual shortage | 60MG | Updated Report | 2025-11-06 | 271251 |
| APO-LEVOTHYROXINE | APOTEX INC | Actual shortage | 50MCG | Updated Report | 2025-11-06 | 262425 |
| APO-DAPAGLIFLOZIN | APOTEX INC | Actual shortage | 10MG | Updated Report | 2025-11-06 | 267020 |
| APO-NADOLOL | APOTEX INC | Actual shortage | 40MG | Updated Report | 2025-11-06 | 269344 |
| ONDANSETRON INJECTION USP | STERIMAX INC | Actual shortage | 2MG | Updated Report | 2025-11-06 | 271238 |
| GLYCOPYRROLATE INJECTION USP | STERIMAX INC | Actual shortage | 0.4MG | Updated Report | 2025-11-06 | 271235 |
| TEVA-ONDANSETRON | TEVA CANADA LIMITED | Actual shortage | 8MG | New Report | 2025-11-06 | 271232 |
| TEVA-ONDANSETRON | TEVA CANADA LIMITED | Actual shortage | 4MG | New Report | 2025-11-06 | 271229 |
Discontinuation Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| ISENTRESS | MERCK CANADA INC | Discontinued | 25MG | Updated Report | 2025-11-08 | 263516 |
| CLINDOXYL GEL | GLAXOSMITHKLINE INC | To be discontinued | 5% 1% | Updated Report | 2025-11-07 | 270515 |
| ATIVAN | PFIZER CANADA ULC | Discontinued | 2MG | Updated Report | 2025-11-03 | 269840 |
| ATIVAN | PFIZER CANADA ULC | Discontinued | 1MG | Updated Report | 2025-11-03 | 269837 |
| ATIVAN | PFIZER CANADA ULC | Discontinued | 0.5MG | Updated Report | 2025-11-03 | 269831 |

